{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T14:37:35Z","timestamp":1771511855095,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100017688","name":"Guangdong Provincial Key Laboratory of Construction Foundation","doi-asserted-by":"publisher","award":["2017B030314030"],"award-info":[{"award-number":["2017B030314030"]}],"id":[{"id":"10.13039\/501100017688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["320.6750.2022-20-26"],"award-info":[{"award-number":["320.6750.2022-20-26"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangzhou Science and Technology Bureau program","award":["SL2022B03J01382"],"award-info":[{"award-number":["SL2022B03J01382"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s00228-025-03926-3","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T01:14:30Z","timestamp":1766106870000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lowering cyclosporine trough concentration threshold effectively mitigates acute graft-versus-host disease in children with severe \u03b2-Thalassemia post hematopoietic stem cell transplantation"],"prefix":"10.1007","volume":"82","author":[{"given":"Zhuolin","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianggui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjiao","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingling","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yousi","family":"Miao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolan","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiali","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"issue":"2","key":"3926_CR1","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1016\/S2352-3026(23)00342-3","volume":"11","author":"O Penack","year":"2024","unstructured":"Penack O, Marchetti M, Aljurf M, Arat M, Bonifazi F, Duarte RF et al (2024) Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European society for blood and marrow transplantation. Lancet Haematol 11(2):e147\u2013e159","journal-title":"Lancet Haematol"},{"issue":"22","key":"3926_CR2","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1056\/NEJMra1609337","volume":"377","author":"R Zeiser","year":"2017","unstructured":"Zeiser R, Blazar BR (2017) Acute graft-versus-host disease - biologic process, prevention, and therapy. N Engl J Med 377(22):2167\u20132179","journal-title":"N Engl J Med"},{"issue":"1","key":"3926_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2022.12.024","volume":"90","author":"E Baumrin","year":"2024","unstructured":"Baumrin E, Loren AW, Falk SJ, Mays JW, Cowen EW (2024) Chronic graft-versus-host disease. Part I: epidemiology, pathogenesis, and clinical manifestations. J Am Acad Dermatol 90(1):1\u201316","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"3926_CR4","first-page":"525","volume":"45","author":"[Chinese expert consensus on the diagnosis","year":"2024","unstructured":"[Chinese expert consensus on the diagnosis (2024) And treatment of acute graft-versus-host disease after hematopoietic stem cell transplantation (2024)]. Zhonghua Xue Ye Xue Za Zhi 45(6):525\u2013533","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"6","key":"3926_CR5","doi-asserted-by":"publisher","first-page":"472","DOI":"10.2165\/00003088-199324060-00004","volume":"24","author":"A Fahr","year":"1993","unstructured":"Fahr A (1993) Cyclosporin clinical pharmacokinetics. Clin Pharmacokinet 24(6):472\u2013495","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"3926_CR6","doi-asserted-by":"publisher","first-page":"953","DOI":"10.2165\/00003495-199345060-00007","volume":"45","author":"D Faulds","year":"1993","unstructured":"Faulds D, Goa KL, Benfield P (1993) Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders. Drugs 45(6):953\u20131040","journal-title":"Drugs"},{"issue":"1","key":"3926_CR7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.bbmt.2009.08.010","volume":"16","author":"F Malard","year":"2010","unstructured":"Malard F, Szydlo RM, Brissot E, Chevallier P, Guillaume T, Delaunay J et al (2010) Impact of cyclosporine-A concentration on the incidence of severe acute graft-versus-host disease after allogeneic stem cell transplantation. Biol Blood Marrow Transplant 16(1):28\u201334","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"3926_CR8","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.jcyt.2024.02.003","volume":"26","author":"A Nikoloudis","year":"2024","unstructured":"Nikoloudis A, Buxhofer-Ausch V, Aichinger C, Binder M, Hasengruber P, Kaynak E et al (2024) Impact of early cyclosporine A levels on acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation using in vivo T-cell depletion. Cytotherapy 26(5):490\u2013497","journal-title":"Cytotherapy"},{"issue":"11","key":"3926_CR9","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1002\/ajh.20710","volume":"81","author":"Y Kanda","year":"2006","unstructured":"Kanda Y, Hyo R, Yamashita T, Fujimaki K, Oshima K, Onoda M et al (2006) Effect of blood cyclosporine concentration on the outcome of hematopoietic stem cell transplantation from an HLA-matched sibling donor. Am J Hematol 81(11):838\u2013844","journal-title":"Am J Hematol"},{"issue":"1","key":"3926_CR10","doi-asserted-by":"publisher","first-page":"2275893","DOI":"10.1080\/16078454.2023.2275893","volume":"28","author":"Q Fan","year":"2023","unstructured":"Fan Q, Hui X, Li X, Li Q, Yang D, Wang Y (2023) Reaching the cyclosporine A level target slowly in four weeks correlates with better prognosis for Chinese patients after allogeneic haematopoietic cell transplantation. Hematology 28(1):2275893","journal-title":"Hematology"},{"issue":"1","key":"3926_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/ejh.13233","volume":"103","author":"N Stocker","year":"2019","unstructured":"Stocker N, Dul\u00e9ry R, Battipaglia G, Brissot E, M\u00e9diavilla C, Sestili S et al (2019) Impact of cyclosporine A concentration on acute graft-vs-host disease incidence after haploidentical hematopoietic cell transplantation. Eur J Haematol 103(1):10\u201317","journal-title":"Eur J Haematol"},{"issue":"3","key":"3926_CR12","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1111\/j.1365-2249.1994.tb07029.x","volume":"95","author":"RM McDouall","year":"1994","unstructured":"McDouall RM, Suitters AJ, Smith H, Yacoub MH, Rose ML (1994) Increased cyclosporine sensitivity of T cells from cord blood compared with those from the adult. Clin Exp Immunol 95(3):519\u2013524","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"3926_CR13","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1097\/FTD.0b013e3182697655","volume":"34","author":"H Billing","year":"2012","unstructured":"Billing H, Sommerer C, Giese T, Zeier M, Meuer S, Czock D et al (2012) Increased cyclosporin A sensitivity in vivo in pediatric renal transplant recipients compared with adults. Ther Drug Monit 34(5):554\u2013560","journal-title":"Ther Drug Monit"},{"issue":"2","key":"3926_CR14","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/biomet\/68.2.373","volume":"68","author":"RL Prentice","year":"1981","unstructured":"Prentice RL, Williams BJ, Peterson AV (1981) On the regression analysis of multivariate failure time data. Biometrika 68(2):373\u2013379","journal-title":"Biometrika"},{"issue":"1","key":"3926_CR15","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/bmt.2013.139","volume":"49","author":"JR Rogosheske","year":"2014","unstructured":"Rogosheske JR, Fargen AD, DeFor TE, Warlick E, Arora M, Blazar BR et al (2014) Higher therapeutic CsA levels early post transplantation reduce risk of acute GVHD and improves survival. Bone Marrow Transplant 49(1):122\u2013125","journal-title":"Bone Marrow Transplant"},{"key":"3926_CR16","unstructured":"Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al (1995) 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 15(6):825\u2013828"},{"issue":"6","key":"3926_CR17","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nri3212","volume":"12","author":"BR Blazar","year":"2012","unstructured":"Blazar BR, Murphy WJ, Abedi M (2012) Advances in graft-versus-host disease biology and therapy. Nat Rev Immunol 12(6):443\u2013458","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"3926_CR18","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1182\/blood-2006-08-044529","volume":"109","author":"VH Nguyen","year":"2007","unstructured":"Nguyen VH, Zeiser R, Dasilva DL, Chang DS, Beilhack A, Contag CH et al (2007) In vivo dynamics of regulatory T-cell trafficking and survival predict effective strategies to control graft-versus-host disease following allogeneic transplantation. Blood 109(6):2649\u20132656","journal-title":"Blood"},{"issue":"4","key":"3926_CR19","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13220","volume":"32","author":"X Yang","year":"2018","unstructured":"Yang X, Yang S, Sun A, Qiu H, Tang X, Han Y et al (2018) Impact of cyclosporine-A concentration in T-cell replete haploidentical allogeneic stem cell transplantation. Clin Transplant 32(4):e13220","journal-title":"Clin Transplant"},{"issue":"3","key":"3926_CR20","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.bbmt.2011.08.016","volume":"18","author":"R Ram","year":"2012","unstructured":"Ram R, Storer B, Mielcarek M, Sandmaier BM, Maloney DG, Martin PJ et al (2012) Association between calcineurin inhibitor blood concentrations and outcomes after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 18(3):414\u2013422","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"3926_CR21","doi-asserted-by":"publisher","first-page":"e0213913","DOI":"10.1371\/journal.pone.0213913","volume":"14","author":"EA de Kort","year":"2019","unstructured":"de Kort EA, de Lil HS, Bremmers MEJ, van Groningen LFJ, Blijlevens NMA, Huls G et al (2019) Cyclosporine A trough concentrations are associated with acute GvHD after non-myeloablative allogeneic hematopoietic cell transplantation. PLoS One 14(3):e0213913","journal-title":"PLoS One"},{"issue":"7","key":"3926_CR22","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s00228-017-2234-2","volume":"73","author":"S Lichtenberg","year":"2017","unstructured":"Lichtenberg S, Rahamimov R, Green H, Fox BD, Mor E, Gafter U et al (2017) The incidence of post-transplant cancer among kidney transplant recipients is associated with the level of tacrolimus exposure during the first year after transplantation. Eur J Clin Pharmacol 73(7):819\u2013826","journal-title":"Eur J Clin Pharmacol"},{"issue":"17","key":"3926_CR23","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1093\/eurjpc\/zwad297","volume":"30","author":"Z Xiao","year":"2023","unstructured":"Xiao Z, Lin Z, Xu L, Xu W, Huang H, Wang Y et al (2023) Cumulative remnant cholesterol predicts cardiovascular outcomes in elderly patients with atherosclerotic cardiovascular disease. Eur J Prev Cardiol 30(17):1924\u20131934","journal-title":"Eur J Prev Cardiol"},{"key":"3926_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.929598","volume":"13","author":"S Duan","year":"2022","unstructured":"Duan S, Lu F, Wu B, Zhang C, Nie G, Sun L et al (2022) Association of serum 25 (OH) vitamin D with chronic kidney disease progression in type 2 diabetes. Front Endocrinol (Lausanne) 13:929598","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"3926_CR25","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1182\/blood-2011-06-364265","volume":"119","author":"M Jagasia","year":"2012","unstructured":"Jagasia M, Arora M, Flowers MED, Chao NJ, McCarthy PL, Cutler CS et al (2012) Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Blood 119(1):296\u2013307","journal-title":"Blood"},{"issue":"2","key":"3926_CR26","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1182\/blood-2001-11-0057","volume":"100","author":"A Urbano-Ispizua","year":"2002","unstructured":"Urbano-Ispizua A, Rozman C, Pimentel P, Solano C, de la Rubia J, Brunet S et al (2002) Risk factors for acute graft-versus-host disease in patients undergoing transplantation with CD34\u2009+\u2009selected blood cells from HLA-identical siblings. Blood 100(2):724\u2013727","journal-title":"Blood"},{"issue":"8","key":"3926_CR27","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/sj.bmt.1704213","volume":"32","author":"P Martin","year":"2003","unstructured":"Martin P, Bleyzac N, Souillet G, Galambrun C, Bertrand Y, Maire PH et al (2003) Relationship between CsA trough blood concentration and severity of acute graft-versus-host disease after paediatric stem cell transplantation from matched-sibling or unrelated donors. Bone Marrow Transplant 32(8):777\u2013784","journal-title":"Bone Marrow Transplant"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-025-03926-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-025-03926-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-025-03926-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T13:38:58Z","timestamp":1771508338000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-025-03926-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["3926"],"URL":"https:\/\/doi.org\/10.1007\/s00228-025-03926-3","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"5 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted according to the Declaration of Helsinki and approved by the Ethics Committee of Guangzhou Women and Children\u2019s Medical Center (Title of the approved project: Study on individualized medication for acute graft-versus-host disease after hematopoietic stem cell transplantation in children; Name of the institutional approval committee or unit: Ethics Committee of Guangzhou Women and Children\u2019s Medical Center; Approval number: Guangzhou Women and Children\u2019s Medical Center, Issue No.63100 [2020], EC; Date of approval: November 27, 2020), and it was registered at Chinese Clinical Trial Registry (ChiCTR2000040561). All patients\u2019 guardians signed informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}